U.S. to begin health screenings at three airports for cases of novel Chinese virus
U.S. authorities on Friday are set to begin screening travelers arriving in the country from…
Author: STAT
STAT Plus: How swallowing a star might keep you from missing a dose of medicine
SAN FRANCISCO — Plenty of drug industry executives who take over this city for a…
STAT Plus: Pharmalittle: FTC member favors Medicare negotiation on drug prices; BioMarin weighs pricing world’s most expensive drug
Good morning. Elizabeth Cooney here again, channeling Ed Silverman as another week draws to a…
The truth about JPM: Less is more
SAN FRANCISCO — Yet another J.P. Morgan Healthcare Conference is done. Was it worth it?…
STAT Plus: ‘We have a tragedy of the commons’: How a VC thinks his new company can lower drug prices
A venture capitalist made some waves early in the J.P. Morgan Healthcare Conference when he…
Opinion: Microglia: a new target in the brain for depression, Alzheimer’s, and more?
More than a decade ago, I was diagnosed with a string of autoimmune diseases, one…
Opinion: Goop’s pseudoscience ministry comes to Netflix
Gwyneth Paltrow’s reaction to the description of the vulva in episode three of her new…
Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients
Why weren’t there any big deals announced this week? What does the word “equivalar” mean?…
STAT Plus: Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation
WASHINGTON — A Republican member of the Federal Trade Commission on Thursday expressed support for…
STAT Plus: Lilly exec says ‘there are no villains’ in the high-priced insulin market
Several months ago, Eli Lilly (LLY) launched LisPro, an authorized generic version of its Humalog…
STAT Plus: A venture firm warms to funding neuroscience
Longtime venture capital star Beth Seidenberg and former Amgen R&D chief Sean Harper say they…
15% of U.S. adults are physically inactive, new CDC data show
More than 1 in 7 adults across all U.S. states and territories are physically inactive,…
Opinion: The public science behind the ‘Merck’ Ebola vaccine
The U.S. Food and Drug Administration recently approved an important vaccine against Ebola, five years…
Three African nations roll out first malaria vaccine in closely watched trial
TOMALI, Malawi — A pinch in the leg, a squeal, and a trickle of tears….
Previously unseen mutations in stem cells of young donors can be passed to recipients, study finds
Doctors use stem cell transplants to treat patients with certain cancers or blood disorders. And…
Chinese health officials can’t rule out person-to-person spread of new virus
BEIJING — The possibility that a new virus in central China could spread between humans…
STAT Plus: Regeneron’s Yancopoulos is still bitter over Praluent sales. Can Novartis do better?
SAN FRANCISCO — George Yancopoulos, Regeneron Pharma’s top scientist, is still a bit bitter about…
Opinion: Using states as living laboratories to solve surprise medical billing
Although surprise billing has been the subject of vigorous debate in federal and state legislatures,…
Opinion: ‘Stuck in a tornado of life’: a patient’s chaos narrative
Cheryl overdosed on heroin — or so she’d hoped — the night before. But that’s…
‘How long do I have?’ A website on cancer survival rates, from the co-founder of GoodRx, seeks to provide clarity
Talking about cancer is hard. Talking about your chances of surviving cancer is even harder….
STAT Plus: Startup Spotlight: With a different method for gene therapy, Generation Bio eyes an IPO
Seven years ago, one of Generation Bio’s scientific founders couldn’t convince any top-tier journals to…
STAT Plus: At JPM, a debate on Alzheimer’s disease, some family drama in oncology, and a beaten-down biotech
SAN FRANCISCO — While the early hours of biotech’s biggest annual meeting didn’t bring any…
Opinion: Innovation in biotech R&D: New resources offer new hope
Public optimism about American health care seems in short supply if you read the news,…
STAT Plus: Pharmalittle: Roche plans aggressive SMA drug pricing; where are those clinical trial results?
Good morning. Elizabeth Cooney here in Boston while Ed Silverman hobnobs with industry types at…
A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels
SAN FRANCISCO — It was supposed to be a showcase for the way in which…
FDA and NIH let clinical trial sponsors keep results secret, investigation shows
This story was originally published by Science. It is a follow-up to STAT articles in…
Opinion: The downside of strong growth in health care jobs: higher costs
Jobs growth soars (CNBC). November Job Growth Booms (USA Today). US economy smashes forecasts (Business…
Watch: Consumer genetic testing: What do you get for your money?
There are about 6.4 billion individual letters in the human genome. More and more, advertisements…
STAT Plus: Pharmalittle: AstraZeneca fish oil pill flops; boom in biopharma dealmaking predicted for 2020
Good morning. Elizabeth Cooney sitting in for Ed Silverman, who is covering the J.P. Morgan…
STAT Plus: Eyeing more data, Livongo will integrate continuous glucose monitor into diabetes coaching program
SAN FRANCISCO — For companies that monitor and coach patients with chronic disease, there are…
High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’
The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic…
Woman with novel pneumonia virus hospitalized in Thailand — the first case outside China
Health authorities on Monday identified a pneumonia case caused by a previously unknown virus in…
STAT Plus: AstraZeneca fish oil drug fails, leaving Amarin as last drug standing
AstraZeneca (AZN) said Monday that it would stop a large clinical study of a fish-oil-derived…
Opinion: What roulette and basketball can teach Biogen about aducanumab
Say that one day you see me walk up to a roulette table and win…
STAT Plus: Facebook’s new tool promotes preventive health. But the company can’t tell if it’s working
LAS VEGAS — As Facebook’s newest health tool makes its way to your feed, the…
A ‘radical proposition’: A health care veteran tries to upend the system and bring drug prices down
The U.S. health system could get some relief from rising drug prices from an unlikely…
STAT Plus: Supreme Court will review an Arkansas law governing pharmacy benefit managers
In a move with the potential to affect health care costs, the U.S. Supreme Court…
First death from Wuhan pneumonia outbreak reported as scientists release DNA sequence of virus
Health authorities in the Chinese city of Wuhan on Saturday reported the first death from…
STAT Plus: Apple came to the world’s biggest tech conference for the first time in 28 years. It barely talked about health
Breaking a 28-year hiatus, Apple made an appearance this week at the annual Consumer Electronics…
STAT Plus: Not so fast: 5 reasons to view declining cancer death rates with a dash of skepticism
Not to be a downer at the start of the new year, but might it…
STAT Plus: Pharmalittle: Combining antibiotics may cause resistance; Lilly moves into dermatitis market with $1.1 billion deal
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for…
Opinion: Welcome to the bioengineering culture clash
Bioengineering, once viewed primarily as an academic discipline, is growing up. Our ability to engineer…
At CES, digital health gadgets gave me a detailed accounting of my flaws and failures
LAS VEGAS — I have 905 pores, 20 wrinkles, and a face that looks 13%…
STAT Plus: Blueprint gains approval for its first drug, a treatment for a rare gastrointestinal cancer
Blueprint Medicines won approval Thursday of its first drug, a precision medicine that dramatically shrank…
STAT Plus: Bristol-Myers and Sanofi accuse Hawaii of violating their free speech rights
In an unusual move, two of the world’s biggest drug makers — Bristol-Myers Squibb (BMY)…
Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory…
STAT Plus: Pharmalittle: More companies recall heartburn tablets; Merck’s Keytruda wins another cancer approval
Top of the morning to you, and a fine one, it is, thanks to clear…
STAT Plus: Pharmalittle: More companies recall heartburn tablets; Merck’s Keytruda wins another cancer approval
Top of the morning to you, and a fine one, it is, thanks to clear…
Chinese scientists obtain genetic sequence of mysterious virus, a key step in containment efforts
Chinese scientists have recovered a previously unknown virus from an infected individual and generated a…